A company description is not available for this instrument.
Research context
Global Cord Blood Corp appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Global Cord Blood Corporation is currently in a long term uptrend where the price is trading 17.1% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.2.
Global Cord Blood Corporation's total revenue sank by 13.1% to $291M since the same quarter in the previous year.
Its net income has dropped by 19.6% to $117M since the same quarter in the previous year.
Finally, its free cash flow grew by inf% to $624M since the same quarter in the previous year.
Based on the above factors, Global Cord Blood Corporation gets an overall score of 3/5.